H.C. Wainwright: Vertex's Long-Term Value Is In The Pipeline By: Benzinga via Benzinga April 28, 2016 at 11:57 AM EDT H.C. Wainwright’s Andrew S. Fein believes the bull thesis for Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) can no longer ... Read More >> Related Stocks: Vertex Pharmaceuticals